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The predicted 80 open reading frames (ORFs) of herpes simplex virus 1 (HSV-1) have been
intensively studied for decades. Here, we unravel the complete viral transcriptome and
translatome during lytic infection with base-pair resolution by computational integration of
multi-omics data. We identify a total of 201 transcripts and 284 ORFs including all known and
46 novel large ORFs. This includes a so far unknown ORF in the locus deleted in the FDA-
approved oncolytic virus Imlygic. Multiple transcript isoforms expressed from individual gene
loci explain translation of the vast majority of ORFs as well as N-terminal extensions (NTEs)
and truncations. We show that NTEs with non-canonical start codons govern the subcellular
protein localization and packaging of key viral regulators and structural proteins. We extend
the current nomenclature to include all viral gene products and provide a genome browser
that visualizes all the obtained data from whole genome to single-nucleotide resolution.
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Herpes simplex virus 1 (HSV-1) is the causative agent of thecommon cold sores but also responsible for severe, life-threatening disease including generalized skin infections,
pneumonia, hepatitis, and encephalitis1. The HSV-1 genome is
about 152 kb in size and known to encode at least 80 open
reading frames (ORFs), many of which have been extensively
studied. Large-scale RNA-seq and ribosome profiling recently
revealed that the coding capacity of three other herpesviruses,
namely human cytomegalovirus (HCMV), Kaposi’s sarcoma-
associated herpesvirus (KSHV) and Epstein-Barr Virus (EBV) is
significantly larger than previously thought2–5. For HCMV and
KSHV in particular, hundreds of viral gene products were iden-
tified. These result from extensively regulated usage of alternative
transcription and translation start sites throughout lytic infection.
Moreover, these viruses were found to encode hundreds of short
ORFs (sORFs) of unknown function. Similar to their cellular
counterparts, these may either regulate translation of viral gene
products or encode for functional viral polypeptides6–10. To date,
the majority of these viral gene products have not been experi-
mentally validated. Furthermore, the lack of a complete annota-
tion and a revised nomenclature severely hampers functional
studies.
Here, we employed a broad spectrum of unbiased functional
genomics approaches and reanalyzed recently published data to
comprehensively characterize HSV-1 gene products (Fig. 1). Our
analysis of the viral transcriptome included: previously published
time-course experiments of (i) total RNA-seq and 4sU-seq data11,
(ii) unpublished transcription start site (TiSS) profiling using two
complementary approaches (cRNA-seq2 and dRNA-seq12), (iii)
incorporation of viral transcripts recently identified by two other
groups using PacBio13 and MinION14 platforms, and (iv) RNA
localization by RNA-seq of subcellular fractions of both wild-type
HSV-115 and the deletion mutant of the key viral RNA export
factor ICP27. Analysis of the viral translatome included: (i)
standard ribosome profiling11 as well as so far unpublished
translation start site (TaSS) profiling using (ii) Harringtonine and
(iii) Lactimidomycin. Viral ORFs were validated using whole-cell
quantitative proteomics and reverse genetics approaches. To
make the annotation and all the obtained data readily accessible
to the research community, we provide an in-house genome
browser software tailored to the visualization of HSV-1 and our
collection of data (available at http://software.erhard-lab.de) as
well as all data files to browse our annotation and data with any
available genome browser at Zenodo16. Thereby, viral gene
expression and all data can be visually examined from whole
genome to single-nucleotide resolution.
In total, we expanded the number of known of HSV-1 genomic
elements to 201 viral transcripts encoding a total of 284 ORFs;
including N-terminal peptide extensions and truncations of sev-
eral classically described viral proteins as well as previously un-
annotated protein-coding sequences in the loci of genes for major
regulatory proteins ICP0 and ICP34.5.
Results
Characterization of the HSV-1 transcriptome. To identify the
full complement of viral transcripts, we performed TiSS profiling
employing a modified RNA sequencing protocol that is based on
circularization of RNA fragments (here termed cRNA-seq)2. It
enables quantification of RNA levels as well as identification of 5′
transcript ends by generating a strong enrichment (≈18-fold) of
reads that start at the 5′ RNA ends. With cRNA-seq, we identified
266 potential TiSS (see Supplementary Methods criteria ii–iv)
that explained the expression of many previously annotated viral
coding sequences (CDS). To comprehensively identify and vali-
date putative TiSS, we applied a second 5′-end sequencing
approach termed differential RNA-seq (dRNA-seq)12, which
provides a much stronger (≈300-fold) enrichment of TiSS at
increased sensitivity (446 potential TiSS, see Supplementary
Methods criterion i). It is based on selective cloning and
sequencing of the 5′-ends of cap-protected RNA molecules that
are resistant to the 5′–3′-exonuclease Xrn1. The two approaches
provided highly consistent data at single-nucleotide resolution
(Fig. 2a). Furthermore, we reassessed viral transcripts called by
two other groups exclusively based on third-generation sequen-
cing techniques (MinION14 and PacBio13 platforms, see Sup-
plementary Methods criteria v and vi). This confirmed many of
our TiSS (Supplementary Fig. 1a,b). The 80 viral transcripts
(corresponding to a total of 89 TiSS, some of which were only
separated by 5 nt), which were recently identified using MinION
data, generally lacked 7-18 nucleotides (nt) at the 5′ end due to
technical limitations of the MinION direct RNA sequencing
method (Supplementary Fig. 1b)17. After correcting this bias
using our data, MinION-derived TiSS were highly consistent with
our cRNA-seq and dRNA-seq data (Fig. 2b). Only 11 of the 89
TiSS (12%) identified by Depledge et al. could not be confirmed.
We thus did not adopt them into our final genome annotation.
Nevertheless, our genome browser encodes a separate track that
visualizes all MinION and PacBio transcripts. Around half of all
the TiSS that were previously identified using PacBio sequen-
cing13 matched to our data with single-nucleotide resolution. The
remaining TiSS (108 of 201; 54%) could neither be confirmed by
cRNA-seq nor dRNA-seq (Fig. 2c). Most of them were only called
from very few reads and presumably represent cleavage products
of larger viral RNAs. This demonstrates that complementary
experiments are essential to exclude false positives and that none
of the approaches by themselves is sufficient to reliably identify all
viral TiSS.
To comprehensively assess the viral TiSS candidates that were
only identified by a single approach, we developed a computa-
tional pipeline termed iTiSS (integrative Transcriptional Start Site
caller). It screens potential TiSS for clustered accumulation of
read 5′-ends in dRNA-seq (i) and cRNA-seq (ii) data. It evaluates
our cRNA-seq data for an increase in upstream to downstream
read coverage at potential TiSS (iii), and temporal changes in the
potential TiSS read clusters in the cRNAs-seq time-course data
(iv). It accounts for TiSS already identified by MinION (v) and
PacBio (vi) sequencing. In addition, we also analyzed our 4sU-seq
time-course data to both score potential TiSS that explained
temporal changes in expression levels throughout infection (vii),
and an increase in upstream to downstream read coverage (viii).
Finally, we also scored TiSS that explained translation of viral
ORFs, for which no other transcript had otherwise been identified
(ix). For more details on each criterion see Supplementary
Methods. Thus, 9 criteria were utilized to confirm a potential
TiSS. All identified TiSS were manually assessed and curated. In
total, this resulted in 189 bona fide viral TiSS, of which 161 (85%)
were called by at least 2 criteria (Fig. 2d). Three of the five
transcripts (LAT18, AL-RNA19, and US5.120), which we could not
confirm by any method, had previously been convincingly
validated by other groups and were thus included. The other
two were included after careful manual inspection (see Supple-
mentary Methods). The complete set of HSV-1 transcripts with
their respective scores is provided in Supplementary Data 1.
TATA-boxes are a key element of eukaryotic promoters located
25–30 bp upstream of the TiSS21. They are also prevalent for
herpesvirus genes22. We used our dRNA-seq data to categorize
viral RNAs into three transcription categories (high, mid and low
transcription). A TATA-box or TATA-box-like motif was found
significantly more often in the highly transcribed category than in
the lowly transcribed one (p < 10−6, Fisher’s exact test). In
mammalian cells, the TiSS is marked by the initiator element
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(Inr), the core of which is a pyrimidine-purine (PyPu)
dinucleotide23. Interestingly, PyPu was also prevalent for the
viral TiSS independent of expression levels (Fig. 2e). This
provides strong evidence for the TiSS of even the most weakly
expressed viral transcripts.
We next looked at splicing within the HSV-1 transcriptome
based on our total RNA-seq and 4sU-seq data11. We first
identified all unique reads that spanned putative exon-exon
junctions by at least 10 nt. This confirmed all 8 well-described
splicing events and identified an additional tandem acceptor site
(NAGNAG)24 for both the third exon of the ICP0 gene (RL2) and
the UL36.6 gene. Recently, Tombácz et al. proposed 11 splicing
events based on PacBio sequencing data13. Our data confirmed all
of these splicing events. However, only 4 of them occurred at
relevant levels compared to the overall transcript levels
(Supplementary Data 2). Two of these explained translation of
small ORFs (UL40.5 iORF and UL40.7 dORF). Finally, we
identified 44 so far unknown putative splicing event sites based
on our Illumina data (Supplementary Fig. 2 and Supplementary
Data 2). However, all of these showed substantially lower read
coverage than the surrounding exons, indicating that they only
represented rare events at best. Therefore, we decided not to
include these low abundance splicing events into our final
reference annotation.
A recent paper by Tang et al.25 proposed 71 novel HSV-1
splicing events. We also observed 15 of these in our Illumina data.
Interestingly, about half (28 of 71) of their splicing events
reported were exclusively observed upon infection with an ICP27
null mutant. Of note, none of our 44 putative splicing events were
found to be more abundant upon infection with an ICP27-null
mutant (subcellular RNA fractions from ΔICP27-infected cells).
We conclude that they do not reflect aberrant splicing events that
originate from infected cells, which express insufficient levels of
ICP27. In total, we thus identified 189 viral TiSS that give rise to
at least 201 transcripts and transcript isoforms.
RNA 3′-end processing and export of viral transcripts. Previous
studies reported regulated usage of the 47 viral poly(A) sites
during productive infection, which appeared to be mediated or at
least influenced by the viral ICP27 protein26–31. We recently
reported that lytic HSV-1 infection results in a widespread but
nevertheless selective disruption of transcription termination of
host genes11. In contrast to the extensive read-through tran-
scription at host poly(A) sites that we observed by 4–8 h p.i., viral
gene expression remained mostly unaffected. Recently published
third-generation sequencing data proposed numerous very large
viral transcripts spanning multiple viral genes14. To address the
nature of these transcripts and their role in translation, we per-
formed RNA-seq on subcellular RNA fractions (total RNA,
cytoplasmic RNA, nucleoplasmic RNA and chromatin-associated
RNA) using both wild-type HSV-1 and a null mutant of the viral
RNA export factor ICP27 (ΔICP27). The data from wild-type
HSV-1 and mock infected cells were recently published15. The
ΔICP27 infection had been performed in the same experiment.
Consistent with the well-characterized role of ICP27 in viral
mRNA export32, all viral transcripts appeared to be more effi-
ciently (≈11-fold) exported to the cytoplasm in wild-type than in
ΔICP27 HSV-1 infection (Fig. 2f). Interestingly, this even inclu-
ded the spliced immediate early (IE) genes ICP0 (≈5-fold), ICP22
(≈17-fold) and ICP47 (≈27-fold) as well as the unspliced (IE)
ICP4 gene (≈11-fold). In chromatin-associated, nuclear and total
cellular RNA, considerable numbers of reads were observed
within the first 500 nt downstream of viral poly(A) sites (PAS).
1Total, cytoplasmic, nucleoplasmic and chromatin-associated RNA (Mock, WT, ΔICP27)
Whole proteome data from 0, 4, 9 and 15 h p.i. of primary human lung fibroblasts (MOI = 10)
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Fig. 1 Overview of the applied Omics approaches. Viral gene expression was analyzed in primary human fibroblasts (HFF). The total RNA-seq, 4sU-seq
and ribosome profiling data were recently published11. To comprehensively identify transcription start site (TiSS), we performed cRNA-seq2 and dRNA-
seq12 as well as RNA-seq on subcellular RNA fractions from mock, wild-type and ΔICP27-infected cells. For all of these, two biological replicates were
performed. Furthermore, we incorporated the recently published transcripts originating from PacBio13 and MinION14 sequencing data. Translation start site
(TaSS) profiling was performed by ribosome profiling following treatment of cells for 30min with either Harringtonine or Lactimidomycin2. Proteome
analysis included two whole-proteome datasets using SILAC and label-free mass spectrometry. The available timepoints and conditions are indicated
by stars.
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Fig. 2 Analysis of viral transcription start sites (TiSS). a Screenshot of our HSV-1 viewer displaying the annotated mRNAs of MinION, PacBio and
coverage of read 5’-ends for cRNA-seq and dRNA-seq of the UL22.5-UL25 gene locus. Transcripts in our reference annotation are indicated in blue. b, c
Venn diagram depicting the number of Transcription start sites (TiSS) that were identified by cRNA-seq, dRNA-seq and MinION14 (b) or PacBio13 (c)
sequencing, respectively. TiSS included into the final annotation are indicated by the black circle. d Histogram depicting the number of TiSS criteria that
were fulfilled by the individual viral transcripts. e Sequence logos upstream of viral TiSS with viral TiSS grouped into three equally sized bins according to
their transcription rates (top: highest; bottom: lowest). The TATA-box and initiator element (Inr) are shown. f Log fold-change between cytoplasmic and
chromatin-associated FPKM-normalized read counts (export index) of cellular (gray) and viral (red and blue) gene clusters compared between wild-type
HSV-1 (wt) and a null mutant of the viral RNA export factor ICP27 (ΔICP27). Viral immediate early genes are indicated in blue.
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However, in the cytoplasmic RNA fraction of infected cells, read
levels dropped substantially immediately downstream of the PAS
(Fig. 3a). This indicates that reads mapping downstream of the
PAS reflect mRNA precursors, which remain nuclear and, thus,
do not contribute to the translated viral transcriptome. However,
for some viral genes, e.g., UL30, UL38, and UL43, considerable
numbers of reads that mapped downstream of the respective PAS
were present in the cytoplasmic RNA fraction. For the UL30 PAS,
this became substantially more prominent late in infection (8 h p.
i., Fig. 3b). Furthermore, transcription of UL25, which initiates
107 nt upstream of the UL24 PAS, efficiently bypassed the UL24
PAS already from 2 h p.i. on (Supplementary Fig. 3). The same
was observed for UL24.5 which represents an N-terminal trun-
cated isoform of UL24. These data confirm previous findings on
differential polyadenylation of selected viral genes during pro-
ductive infection26–30.
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Fig. 3 Subcellular localization of viral transcripts. a Read levels 500 bp upstream (left) and downstream (right) of the Poly(A)-site (PAS) of viral genes
for wild-type HSV-1. Gray bars indicate overlapping parts with other genes, for which reads could not be uniquely assigned. In the cytoplasmic RNA
fraction, read levels dropped substantially immediately downstream of the PAS. p-values were calculated using a one-sided paired t-test over the mean
fold-change of read levels 500 bp before against after the PAS (Cytoplasmic to Nucleoplasmic: p-value= 8.157 × 10−4, Cytoplasmic to chromatin-
associated: p-value= 6.956 × 10−8, Cytoplasmic to total p-value= 4.06 × 10−4). b Screenshot of our HSV-1 viewer depicting poly(A) read-through at the
UL30 PAS in cRNA-seq data at 2, 4, and 8 h post infection (hpi) of replicate 1. The annotated transcripts (mRNA), proteins (Proteins) and read coverage
(Coverage) for chromatin-associated, nucleoplasmic, cytoplasmic and total reads are shown for the positive strand only. Read-through transcription is
schematically indicated in red. Downstream of the UL30 PAS, chromatin-associated and nucleoplasmic reads show substantial read-through, whereas
cytoplasmic reads drop down to only a fraction of what they were before (blue arrow).
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HSV-1 expresses hundreds of so far unknown ORFs and
sORFs. To comprehensively identify the viral translatome, we
performed time-course analysis of ribosome profiling as well as
translation start site (TaSS) profiling (see Fig. 1 and Supple-
mentary Methods). The obtained data confirmed the expression
of all 80 previously annotated ORFs (CDS) and detected 46
additional large ORFs and 134 small ORFs (3–99 aa). We also
identified 7 N-terminal truncations (NTTs) and 17 N-terminal
extensions (NTEs) of CDS. In total, our data provides evidence
for the translation of 284 viral ORFs (Supplementary Data 3 and
4). Translation predominantly initiated from AUG start codons
(79%). However, non-canonical initiation events also sub-
stantially contributed to the HSV-1 translatome with CUG, GUG,
ACG, and AUC together initiating translation of about 15% and
20% of all large and small viral ORFs, respectively (Fig. 4a, b).
We observed seven NTTs originating from downstream
translation initiation events of previously described viral coding
sequences (Supplementary Data 5). All of these initiated with
AUG start codons (Fig. 4c). Alternative TiSS downstream of the
main TiSS explained translation of 6 of 7 NTTs (Supplementary
Fig. 4). Only for US3.5, we could not identify a corresponding
transcript. It thus remains unclear whether US3.5 is translated
from an independent transcript or due to leaky scanning. Six of
these NTTs (UL8.5, UL12.5, UL24.5, UL26.5, US1.5, and US3.5)
had already been reported33–38. Only the NTT of the major
DNA-binding protein pUL29 (ICP8; comprising aa 516–1212)
had so far not been described. Interestingly, this NTT initiates at
an AUG start codon immediately downstream of the metal-(Zn)-
binding loop (residues 499–512)39,40. While the ribosome
profiling data showed a strong peak at the respective AUG start
codon, which was further enriched by LTM treatment (Supple-
mentary Fig. 4), we were unable to validate the truncated UL29.5
protein using a C-terminally 3×-Flag-tagged mutant virus.
Further experiments are thus required to clarify the existence
and stability of UL29.5 as well as its corresponding transcript.
Interestingly, 16 of the 80 viral reference ORFs (20%) showed
in-frame NTEs (Supplementary Data 6) with translational activity
exceeding 10% of the main downstream ORF. The majority of
NTEs (16 of 17, including 2 NTEs in UL50) initiated translation
from non-AUG start codons (Fig. 4d). This included key viral
proteins like the major immediate early protein ICP27 (UL54),
the major capsid protein (VP5, UL19) and the well-studied viral
kinase US3. For five viral genes, we generated mutant viruses by
introducing a 3×-FLAG-tag either into the NTE or downstream
of the canonical AUG start codon. This confirmed the expression
of 6 NTEs including the 2 UL50 NTEs (Fig. 5a–e). Interestingly,
the introduction of a 3×-FLAG-tag into the N-terminal extension
of both ICP27 and VP5 resulted in dead viruses, which could only
be reconstituted upon transfection of complementing cells. For
UL54, expression of the NTE was already observable when the
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(uninf.) and the parental (WT) virus, both at 24 h p.i. for the HSV-1 genes a US3, b US5, c UL19, d UL50, and e UL54. Expression of the NTE of UL54
(ICP27) was already visible when the 3×-FLAG-tag was inserted downstream of the canonical AUG. f Immunofluorescence of human foreskin fibroblasts
infected with mCherry-VP26 HSV-1 containing 3×-FLAG-tags inserted upstream of the canonical start codon into the N-terminal extension (NTE) or
downstream of it (AUG) for US3 and g UL50. Cell nuclei were stained using DAPI. Scale bars depict 20 microns. Protein localization of both NTEs shifts to
the cytoplasm. Source data are provided within the Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15992-5 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:2038 | https://doi.org/10.1038/s41467-020-15992-5 | www.nature.com/naturecommunications 7
3×-FLAG-tag was introduced downstream of the canonical AUG
start codon (Fig. 5e). For UL19 (VP5) major capsid protein
(MCP), the 3×-FLAG-tagged NTE appeared to even be dominant
negative. Virus reconstitution in non-complementing cells
resulted in a partial deletion of the NTE within two passages.
This indicates that the 3×-FLAG-tagged NTE-MCP is assembled
into virus particles but renders them dysfunctional due to the N-
terminally inserted 3×-FLAG-tag.
To test the impact of the respective NTEs on protein
localization, we performed immunofluorescence microscopy of
both the NTE- and AUG-tagged viruses. While subcellular
localization of the NTEs of UL54 and US5 were indistinguishable
from their canonical counterparts (Supplementary Fig. 5), the
NTEs of US3 and UL50 notably altered subcellular localization
(Fig. 5f, g). While canonical US3 was predominantly nuclear, the
NTE-US3 localized to the cytoplasm. The US3 NTE contains a
leucine-rich stretch indicating a putative nuclear export signal.
Pseudorabies virus (PRV), a porcine alphaherpesvirus, expresses
two isoforms of US3, both of which initiate from AUG start
codons on separate transcripts (Supplementary Fig. 6). The longer
isoform encodes a mitochondrial localization signal resulting in
the cytoplasmic localization and a failure of the respective protein
to be incorporated into the tegument41. The DNA sequence of the
US3 NTE is conserved in HSV-2 and its role as a nuclear export
signal fits data demonstrating that HSV-2 US3 fails to accumulate
in the cytoplasm when nuclear export is inhibited42. Similar to
US3, localization of NTE-UL50 also shifted to the cytoplasm
(Fig. 5g). UL50 dUTPase activity in PRV-infected cells was
reported to be nuclear43, while it appears to be predominantly
cytoplasmic with HSV-244 and nearly equally distributed in HSV-
1. We conclude that NTEs initiating from non-AUG start codons
are common in alphaherpesvirus proteomes. They allow the
expression of alternative protein isoforms with different sub-
cellular localization and regulatory motifs.
In 2015, the first oncolytic virus (talimogene laherparepvec
(Imlygic)) was approved for therapy of melanoma45. This
modified herpes simplex virus 1 lacks two viral genes (ICP34.5
and ICP47) and expresses GM-CSF to recruit and stimulate
antigen-presenting cells. Within the ICP34.5 (RL1) locus, we
found a 93 aa ORF, which we termed RL1A (Fig. 6a). It initiates
from an AUG start codon 46 nt upstream of the AUG start codon
of RL1 and is translated from the same transcript at >4-fold
higher levels. Imlygic thus lacks a third viral protein, namely
RL1A.
The RL2 locus encodes the major viral immediate early protein
ICP0. Here, we identified an additional spliced ORF (termed
RL2A) of 181 aa that initiates from an ACG start codon 116 nt
upstream of the ICP0 TaSS (Fig. 6b). Expression of RL2A was
confirmed by generating a mutant virus (3×-Flag-RL2A) with a
3×-FLAG-tag inserted 12 nt downstream of the ACG start codon
(Fig. 6c). Interestingly, RL2A expression by the mutant virus
could only briefly be detected immediately upon virus reconstitu-
tion and was readily lost upon serial passaging. This indicates that
insertion of the 3×-FLAG-tag into the RL2A repeat region
severely impaired viral fitness resulting in DNA recombination
with the other wild-type repeat. To address this issue, we
generated a second mutant virus (3×-FLAG-RL2A-ΔRL) by
subsequently deleting the wild-type RL2A and part of RL2 from
the second repeat to prevent recombination and removal of the
inserted 3×-Flag-tag upon virus reconstitution and passaging.
This resulted in stable expression of 3×-Flag-tagged RL2A of the
expected size (21.8 kD; Fig. 6c). Interestingly, however, ICP0
expression of this mutant was almost completely abolished. We
subsequently noted that the 3×-FLAG-tag contains an out-of-
frame AUG start codon (GATTACAAGGATGACGACGATAA)
in every of the three FLAG-tag repeats. Translation initiation at
the respective start codons and ribosomes bypassing the ICP0
TaSS explains the observed near-complete loss of ICP0 expression
and thus the rapid recombination of our primary 3×-FLAG-RL2A
mutant upon serial passaging. Furthermore, this may also explain
some of the attenuation, which we observed for the mutant
viruses with 3×-FLAG-tagged NTEs, namely for ICP27 and VP5.
Accordingly, protein levels of the canonical ICP27 protein were
dramatically reduced for the 3×-FLAG-tagged NTE-ICP27 virus
(Supplementary Fig. 5). These observations highlight the need to
carefully consider ectopic translation start site usages when
manipulating herpesvirus genomes.
Transcription of all viral genes continuously increases
throughout lytic infection with the exception of the transcript
encoding ORF-O and ORF-P. These two partially overlapping
ORFs are expressed antisense to the ICP34.5 (RL1) gene46.
Consistent with the previous report, the respective transcript was
already well detectable in 4sU-seq data at 1 h p.i. but transcrip-
tional activity declined rapidly afterwards (Supplementary
Fig. 7a). Nevertheless, translation of the respective transcripts
remained detectable until late times of infection. Interestingly, the
absence of a canonical start codon resulted in the hypothesis that
ORF-O initiates from the same AUG start codon as ORF-P but
then diverges within the first 35 codons due to a ribosomal
frameshift. We did not observe any evidence for frameshifts in the
HSV-1 translatome. While translation of ORF-O was rather weak,
our data indicate that it rather initiates from a non-canonical
ACG start codon 76 nt upstream of the ORF-P (Supplementary
Fig. 7b).
Finally, we also aimed to validate the newly identified HSV-1
ORFs by whole-proteome mass spectrometry. We obtained triple-
SILAC whole-proteome data from HSV-1 infected HFF at 0, 4,
and 8 h p.i (n= 3). Furthermore, we performed whole-proteome
mass spectrometry from primary lung fibroblasts infected with
HSV-1 for 0, 4, 9, and 15 h. In total, this confirmed only 11 (6%)
of the 186 ORFs and sORFs (Supplementary Data 7; excluding
NTEs and NTTs) identified in this study. This rather small
fraction is consistent with previous work on HCMV ORFs2 and
presumably reflects that the majority of viral sORFs are
inherently unstable and rapidly degraded upon translation similar
to their cellular counterparts. Nevertheless, they may play an
important role in regulating translation of the viral ORFs encoded
downstream of them. Furthermore, the identified large viral ORFs
were expressed at substantially lower (~10×) levels than the
previously identified viral protein-coding sequences (Supplemen-
tary Fig. 8).
The complete nomenclature of HSV-1 gene products. The large
number of viral gene products required extension of the current
nomenclature. We first compiled viral gene units comprising
transcript isoforms, ORFs and regulatory entities, e.g., uORFs and
uoORFs (Supplementary Data 3). A detailed description of the
applied rules is provided in the Supplementary Methods. In brief,
we fully maintained the current nomenclature for all ORFs in the
reference annotation1 and attributed each ORF to the most highly
expressed transcript in its vicinity. Alternative transcript isoforms
initiating within less than 500 nucleotides were labeled with “*”
(extended) or “#” (truncated), e.g., UL13 mRNA *1. Finally,
alternatively spliced transcripts were labeled with iso 1 and iso 2.
Short ORFs (<100 aa), were named upstream ORF (uORF),
upstream overlapping ORF (uoORF), internal ORF (iORF) and
downstream ORF (dORF) in relation to the next neighboring
large ORF. Any ORF for which no transcript could be identified
to be responsible for its translation was labeled as orphan. An
overview of the status of the various kinds of ORFs that we
identified is shown in Fig. 6d. In accordance, any transcript,
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which was not found to encode an ORF or sORF within its first
500 nt was also labeled as orphan. Interestingly, we identified 41
orphan transcripts (Supplementary Data 8), which showed pre-
dominantly nuclear localization indicating that they may repre-
sent viral nuclear long non-coding RNAs (lncRNAs). However,
all of them were expressed at rather low levels. Accordingly, we
were unable to validate five of them by Northern blots despite
extensive efforts. We conclude that HSV-1 does not express any
highly transcribed viral non-coding RNAs during lytic infection.
We uploaded the fully reannotated HSV-1 genome information
to the NCBI GenBank Third Party Annotation database (acces-
sion number BK012101).
Discussion
In recent years, major advances in high-throughput experimental
methodology have revealed that herpesvirus gene expression is
surprisingly complex. While a number of studies in the last few
years described hundreds of viral transcripts and ORFs, a sys-
tematic analysis, validation and integration into gene modules,
which attribute individual ORFs and sORFs to specific transcripts
they are expressed from, was not attempted. Moreover, the lack of
a standardized nomenclature has hampered functional studies on
these viral gene products. Based on a wide spectrum of this and
already published functional genomics data, we here provide a
state-of-the-art, fully revised annotation of the HSV-1 genome.
Calling gene products based on big data poses the risk of false
positives. As virus replication already initiates at 2 h p.i., first virus
particles are released at 4 h p.i. and >80% of translational activity in
the infected cells is viral at 8 h p.i.11, we restricted our analysis to the
first 8 h of infection to reduce the risk of detecting aberrant gene
expression in cells with extensive cytopathic disruption of the
transcriptional machinery. Integrative analysis of transcription start
site (TiSS) data obtained by both second (cRNA-seq, dRNA-seq)
and third (PacBio, MinION) generation sequencing approaches
highlighted the necessity to validate viral TiSS by multiple means to
exclude such experimental artifacts generated by the individual
approaches. Similarly, the different transcription profiling approa-
ches identified numerous putative splicing events. However, the vast
majority of these only occurred at very low levels. We restricted our
analysis to the first 8 h of lytic HSV-1 infection and only included
splicing events observed by at least two approaches. While MinION
RL2A
22 33 Mock WT
RL2A
ΔRL
α-ICP0
α-Actin
kDa:
30
25
RL2A
(α-FLAG)
RL2A RL2A
RL2RL2
RL2 iso 1 (retained intron) RL2 dORF
Total.LOG
10
100
1000
ltm.LIN
200
1000
1800
10
100
1000
100
300
500
ACG AUG
RL1
RL1A
AUG
TRL
JN555585 +
TRL
JN555585 +
n = 246
n = 78
n = 17
n = 7
n = 33 n = 47
n = 10 n = 13 n = 7
n = 34n = 38
n = 2 n = 0
n = 13
n = 3 n = 2 n = 4 n = 3 n = 11
Non orphan
Orphan
0
100
200
All CDS NTE NTT ORF uORF uoORF iORF dORF sORF
Orf type
Co
un
t
400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150 1200 1250
3650360035503500345034003350350032503200315031003050300029502900285028002750270026502600255025002450240023502300225022002150
c
b
a
d
Genome
Genome
+.Annotation.Proteins
+.Annotation.Proteins
Total.LOG
Itm.LIN
Fig. 6 Evidence of additional protein-coding sequences. Ribosome profiling data visualizing expression of the two viral open reading frames (ORFs), RL1A
and RL2A (the three colors depicting the read count for each of the three possible frames, yellow= 1, blue= 2, green= 3), expressed from the a RL1 and b
RL2 locus of the terminal repeats (TRL). Both standard ribosome profiling data in log scale (Total.log) as well as translation start site profiling data obtained
using Lactimidomycin (linear scale, ltm.LIN) are shown. The three possible reading frames are colored in yellow (frame 1), blue (frame 2) and green (frame
3). Both ORFs are well expressed and validated by the strong peak of their respective Translation start site (TaSS) in the ltm-track (black arrows). While
RL2A initiates from a non-canonical ACG start codon, the 93 aa RL1A protein initiates from an AUG start codon and was previously missed due to its length
of <100 aa. c Validation of RL2A expression by Western blot. Primary human fibroblasts were infected with two viral clones (22, 33) with one RL segment
expressing a 3×-FLAG-tagged RL2A (RL2A), mock, wild-type HSV-1 (WT; for 24 h) or 3×-FLAG-RL2A-ΔRL (=RL2A-ΔRL) for 24 h. Interestingly, insertion
of the 3×-FLAG-tag resulted in a loss of ICP0 expression presumably due to the introduction of three out-of-frame AUG start codons (within each FLAG-
tag) upstream of the ICP0 TaSS. This was most pronounced when the second repeat was deleted (RL2A-ΔRL). Actin served as house-keeping control. A
representative experiment of two independent experiments is shown. d Distributions of all identified types of ORFs (CDS coding sequence, NTE N-terminal
extended ORFs, NTT N-terminal truncated ORFs, uORF upstream ORF, uoORF upstream overlapping ORF, iORF internal ORF, dORF downstream ORF,
sORF short ORF) of HSV-1 classified by ORFs and orphan ORFs. Source data are provided within the Source Data file.
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sequencing recently identified intergenic splice sites resulting in
fusion proteins (e.g., between ICP0 and glycoprotein L)14, the
respective transcripts only arise very late in infection and their
functional relevance remains unclear. We thus did not include them
into our annotation. We conclude that splicing in the HSV-1
transcriptome was already well described by the previous reference
annotation but rare splicing events may explain some of our orphan
viral ORFs and sORFs.
In eukaryotic cells, RNA polymerase II (Pol II) may continue
transcribing for thousands of nucleotides downstream of the PAS
until transcription is terminated and Pol II is released from the
chromatin47. With viral gene expression rapidly increasing
throughout lytic infection, mRNA precursors with unprocessed 3′-
ends that still extend beyond the canonical polyadenylation site are
likely to be prevalent in the infected cells. Thus, unprocessed viral
pre-mRNAs can easily be misinterpreted as mature viral transcripts.
This presumably explains previous reports of near-complete tran-
scription of herpesviral genomes during productive infections2,48,49.
Analysis of cytoplasmic rather than total RNA provides a more
accurate picture of the mature viral transcriptome. Consistent with
previous reports, we confirmed that the major viral RNA export
factor ICP27 was required for efficient export of all viral tran-
scripts32. Interestingly, this also included all immediate early genes
and spliced viral transcripts.
Ribosome profiling identified 134 sORFs expressed during lytic
HSV-1 infection. The majority of these represent so called
upstream open reading frames (uORFs). Interestingly, a relatively
large fraction of transcript isoforms (~20%) encode their own
uORF, which preferentially (54%) initiate from AUG start
codons. Cellular uORFs constitute an important regulatory net-
work governing gene expression at the level of translation by
affecting translation initiation of the downstream ORF50. Reliable
annotation of both viral transcripts and their respective uORFs
will now enable functional studies on these cryptic viral gene
products. sORF-encoded polypeptides are usually highly unstable
and thus remain undetectable by whole-proteome mass spectro-
metry. Accordingly, we were only able to confirm about 5.5% of
the ORFs identified by ribosome profiling on the peptide level.
Interestingly, we could recently show that peptides derived from
cellular sORFs are nevertheless efficiently incorporated into and
presented by MHC-I molecules on the cell surface despite
remaining virtually undetectable by whole proteome mass spec-
trometry5. Viral sORF-derived peptides thus may constitute a
viral class of antigens that are efficiently presented by MHC-I but,
due to their instability and extremely low abundance within the
cell’s proteome, represent poor substrates for cross-presentation
and CD4-CD8 augmentation. Further studies are necessary to
assess the role of HSV-1 sORFs in the regulation of viral protein
expression, antiviral T cell control and evasion thereof.
Based on our revised annotation of 201 viral transcripts and 284
ORFs, we extended the existing nomenclature to include these all
our novel viral gene products. This did not involve any renaming of
previously described viral gene products. Our nomenclature thereby
explains gene expression of the majority of viral ORFs in the
context of different transcript isoforms, uORF and uoORFs. This
will facilitate functional studies on the viral gene products as well as
their transcriptional and translational regulation.
Methods
Cell culture, viruses, and infections. Human foreskin fibroblasts (HFF,
#86031405, purchased from ECACC), 293T, Vero 2–2 (Smith, Hardwicke, &
Sandri-Goldin, 1992) BHK-21, and BHK-21 dox-UL19 (described below) cell lines
were cultured in flasks containing Dulbecco’s Modified Eagle Medium (DMEM),
high glucose, pyruvate (ThermoFisher #41966052) supplemented with 1x MEM
Non-Essential Amino Acids (ThermoFisher #11140050), 1 mM additional sodium
pyruvate (ThermoFisher #11360070), 10% (v/v) Fetal Bovine Serum (FBS, Bio-
chrom #S 0115), 200 IU/mL penicillin (pen) and 200 µg/mL streptomycin (strep).
WI-38 fibroblasts were cultured in minimal essential media (MEM) supplemented
with 10% FBS, 100 IU/mL penicillin, and 200 µg/mL strep. All cells were incubated
at 37 °C in a 5% (v/v) CO2-enriched incubator.
HFF were utilized from passage 11–17 for all high-throughput experiments.
Virus stocks were produced on baby hamster kidney (BHK) cells except for the
viruses described below. Stocks of the ICP27-null mutant (strain KOS)51 were
produced on complementing Vero 2–2 cells52. HFF were infected for 15 min at 37 °
C about 24 h after the last split using a multiplicity of infection (MOI) of 10.
Subsequently, the inoculum was removed and fresh media was applied to the cells.
To reconstitute the 3×-FLAG-tagged UL19 NTE, BHK-21 dox-UL19 cells with
doxycycline-inducible expression of UL19 were generated by cloning the HSV-1
Syn17+UL19 coding sequence using primers described in Supplementary Data 9
into the SalI and NheI sites of pTH3, a derivative of pCW57.1 with a custom
multiple cloning site in lieu of the gateway cloning site and the addition of the TRE
tight promoter from pTRE-Tight. Lentiviral vectors were generated by
cotransfection of this construct with psPAX2 and pCMV-VSV-G into 293T cells.
Lentivirus-containing supernatants were sterile-filtered with Minisart® NML 0.45
µm cellulose acetate filters (Sartorius #17598) and added to BHK-21 cells.
Polyclonal populations were selected 48 h post-transduction and maintained in 1
µg/mL puromycin.
Viral mutagenesis and reconstitution. All viral mutants were generated via en
passant mutagenesis53 using Escherichia coli strain GS1783 with the bacterial
artificial chromosome (BAC) HSV1(17+)-LoxCheVP2654 expressing a fusion
protein of mCherry on the N-terminus of the UL35 gene product (VP26). Full
primer and construct sequences can be found in Supplementary Data 9. BAC DNA
was purified using the NucleoBond BAC 100 kit (Macherey-Nagel #740579) and
transfected for virus reconstitution into BHK-21 cells with Lipofectamine 3000
(ThermoFisher #L3000-075). HSV-1 expressing the 3×-FLAG-tagged N-terminal
extension of UL54 was reconstituted and titrated on Vero 2–2 cells52. The virus
expressing the tagged N-terminal extension of UL19 was generated in BHK-21
dox-UL19 cells. BHK-21 dox-UL19 cells were plated the day before in media
containing 1 µg/mL doxycycline (Sigma #D3072), which was maintained
throughout virus generation. 3×-FLAG-tagged RL2A BAC-derived viruses were
constructed by insertion of the tag with a kanamycin cassette into one genomic
repeat followed by replacement of the second repeat (region upstream of RL1
through the second exon of RL2) with the ampicillin resistance gene from
pcDNA3. The kanamycin cassette was removed thereafter by traceless mutagenesis.
Virus produced by transfected cells was expanded on minimally five T175 flasks
of the corresponding cell type. Virus-containing supernatants were harvested upon
>90% cytopathic effect and centrifugation at 8000 RCF at 4 °C for 10 min to pellet
cells. Cell pellets were snap-frozen in liquid nitrogen and thawed at 37 °C three
times to free cell-associated virus. Cellular debris was pelleted at 10,000 RCF, 4 °C
for 10 min and supernatant combined with the supernatant in the previous step.
Virions were pelleted by centrifugation at 19,000 RCF for two hours at 4 °C,
resuspended in phosphate-buffed saline (PBS), and pelleted once more over a 20%
(w/v) sucrose cushion in PBS 16,000 RPM for 2 h at 4 °C in a SW 28 swinging-
bucket rotor (Beckman). Virus pellets were resuspended in PBS, snap-frozen in
liquid nitrogen, stored at −80 °C, and titrated by plaque assay. Infections were
carried out in serum-free DMEM containing penicillin and streptomycin for 1 h at
37 °C. The time at which inoculum was replaced with growth media was marked as
the 0 h timepoint.
Western blot. Samples were harvested at the indicated timepoints by removal of
growth media and direct lysis in 2x Laemmli buffer containing 5% (v/v) β-
mercaptoethanol. Samples were sonicated and heated for 5 min at 95 °C before
loading onto a Novex™ WedgeWell™ 4–20% Tris-Glycine Gel (ThermoFisher
#XP04200BOX). Proteins were transferred to polyvinylidene difluoride (PVDF)
membranes, blocked for 1 h at room temperature in 1xPBST containing 5% (w/v)
milk (Carl Roth T145.3), and probed using α-FLAG M2 (Sigma #F1804) overnight
at 4 °C at a 1:1000 at dilution and α-mouse IgG (whole molecule)-peroxidase
(Sigma #9044) for 1 h. β-actin was probed using α-β-actin C4 antibody (Santa Cruz
Biotechnology #sc-47778) at a 1:1000 dilution for 1 h, followed by IRDye® 800CW
goat α-mouse IgG (LI-COR #926-32210) at 1:5000 or α-mouse IgG (whole
molecule)-peroxidase (Sigma #9044) for 1 h. ICP0 and ICP27 were probed using α-
ICP0 clone 5H7 (Santa Cruz Biotechnology #sc-56985) or α-ICP27 clone H1113
(Abcam #ab53480), respectively, at a 1:1000 dilution for 1 h, followed by IRDye®
680RD goat α-mouse IgG (LI-COR #926-68070) at 1:5000 or α-mouse IgG (whole
molecule)-peroxidase (Sigma #9044) for 1 h. Samples were washed with 1xPBST
and blocked before addition of each antibody in the milk/PBST buffer. Blots were
visualized with a LI-COR Odyssey® FC Imaging System.
Immunofluorescence. 105 HFF cells were plated on glass coverslips in 12-well
dishes 24 h prior to infection. At 8 h post-infection, cells were fixed in 4% for-
maldehyde in PBS for 1 h at room temperature, washed three times in PBS and
stored at 4 °C overnight in PBS. Cells were incubated in permeabilization buffer
(10% FBS, 0.25M glycine, 0.2% Triton X-100, 1xPBS) for 1 h at room temperature
before incubating them in blocking buffer (10% FBS, 0.25 M glycine, 1xPBS) for 1 h
at room temperature. Anti-FLAG antibody (GenScript #A00187) was incubated in
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10% FBS and 1xPBS for 1 h at 37 °C at a concentration of 1 μg/mL. The secondary
anti-mouse IgG, Alexa Fluor 488 (ThermoFisher #A11017) was incubated in 10%
FBS in 1xPBS for 1 h at room temperature with 0.5 μg/mL 4’,6-diamidino-2-phe-
nylindole (DAPI). All steps were followed by three 5-min washes in PBS except for
after the primary antibody, which was washed with 1xPBS and 0.05% Tween-20.
Coverslips were washed in water before mounting them in medium containing
Mowiol 4-88 and 2.5% (w/v) 1,4-diazabicyclo[2.2.2]octane (DABCO).
Transcription start site (TiSS) profiling. Total cellular RNA was isolated using
Trizol (Invitrogen) following the manufacturer’s instructions. RNA was resus-
pended in water and stored at −80 °C until use. TiSS profiling dataset using cRNA-
seq utilizes a similar approach as employed for decoding HCMV2. Following rRNA
depletion and extensive chemical RNA fragmentation, 50–80 nt RNA fragments
are recovered by gel extraction. Library preparation is performed by 3′-adaptor
ligation and circularization. This inherently enriches for transcript 5′-ends by 20-
to 30-fold. A detailed protocol is included in the Supplementary Methods. Of note,
our cRNA-seq library preparation protocol introduces a 2+ 3 nt unique molecular
identifier (UMI), which facilitates the subsequent removal of PCR duplicates from
sequencing libraries.
TiSS profiling dataset using dRNA-seq was prepared according to the
published protocol12 with some modifications by the Core Unit Systems
Medicine (Würzburg). In brief, for each sample 3 µg of DNase-digested RNA
was treated with T4 Polynucleotide Kinase (NEB) for 1 h at 37 °C. RNA was
purified with Oligo Clean & Concentrator columns (Zymo) and each sample was
split into an Xrn1 (+Xrn1) and a mock (−Xrn1) sample. The samples were
treated with 1.5 U Xrn1 (NEB; +Xrn1) or water (−Xrn1) for 1 h at 37 °C. Digest
efficiency was checked on a 2100 Bioanalyzer (Agilent) and 5′ caps were
removed by incubation with 20 U of RppH (NEB) for 1 h at 37 °C. Afterwards,
RNA was purified and eluted in 7 µL and 6 µL were used as input material for the
NEBNext® Multiplex Small RNA Library Prep Set for Illumina®. Library
preparation was performed according to the manufacturer’s instruction with the
following modifications: 3′ adapter, SR RT primer and 5′ adapter were diluted
1:2, 13 cycles of PCR were performed with 30 sec of elongation time, and no size
selection was performed at the end of library preparation. Concentrations of
libraries were determined using the Qubit 3.0 (Thermo Scientific) and their
fragment sizes were determined using the Bioanalyzer. Libraries were pooled
equimolar. Sequencing of 75 bp single-end reads was performed on a NextSeq
500 (Illumina) at the Cambridge Genomic Services (cRNA-seq) and the Core
Unit Systems Medicine in Würzburg (dRNA-seq). To validate TiSS identified by
cRNA-seq, dRNA-seq, PacBio or MinION (no reads were reanalyzed, only the
called transcripts were used for PacBio and MinION), total RNA-seq and 4sU-
seq data that were previously published11 were reanalyzed (see below).
RNA-seq of subcellular RNA fractions. Subcellular RNA fractions (cytoplasmic,
nucleoplasmic and chromatin-associated RNA) were prepared by combining two
previously published protocols55,56. Data from uninfected and wild-type HSV-1
infected cells were published recently15. Infection with the ICP27-null mutant was
performed in the same experiment. As for wild-type HSV-1 infection, total cellular
RNA was isolated using Trizol at 8 h p.i. Fractionation efficiencies were confirmed
on the RNA-seq data by comparing expression values of known nuclear and
cytoplasmic RNAs as well as intron contributions (see Supplementary Fig. 9)15.
Sequencing libraries were prepared using the TruSeq Stranded Total RNA kit
(Illumina) following rRNA depletion using Ribo-zero. Sequencing of 75 bp paired-
end reads was performed on a NextSeq 500 (Illumina) at the Cambridge Genomic
Services and the Core Unit Systems Medicine (Würzburg).
Ribosome profiling. The ribosome profiling time-course data (lysis in presence of
cycloheximide) have already been published11. Additionally, so far unpublished
data we generated include translation start site (TaSS) profiling performed by
culturing cells in medium containing either Harringtonine (2 µg/ml) or Lactimi-
domycin (50 µM) for 30 min prior to harvest. Harringtonine samples were
obtained for 2 h and 8 h p.i., Lactimidomycin was employed for mock, 4 and 8 h p.i.
Two replicates of each condition were analyzed. As described for cRNA-seq, the
library preparation protocol introduces a 2+ 3 nt unique molecular identifier
(UMI), which facilitates the subsequent removal of PCR duplicates from sequen-
cing libraries. All libraries were sequenced on a HiSeq 2000 at the Beijing Genomics
Institute in Hong Kong.
Proteomic analysis. WI-38 lung fibroblasts grown in SILAC medium were
infected at MOI 10 and harvested after 4, 9, and 15 h. After cell lysis, protein
concentration was determined by Bradford assay and 200 μg of each sample were
mixed with equal amount protein extracted from untreated cells grown in SILAC
light medium. Additional sample preparation steps are elaborated in the Supple-
mentary Methods. Primary human foreskin fibroblasts were grown for five pas-
sages in DMEM lacking lysine and arginine (Thermo Scientific) supplemented with
10% dialysed FCS (Gibco), 100 units/mL penicillin and 0.1 mg/mL streptomycin,
280 mg/L proline (Sigma) and light (K0, R0; Sigma), medium (K4, R6; Cambridge
Isotope Laboratories) or heavy (K8, R10; Cambridge Isotope Laboratories) 13 C/
15N-containing lysine (K) and arginine (R) at 50 mg/L. Pre-labeled cells were
infected with HSV-1 at a multiplicity of infection (MOI) of 10 for 4 or 8 h, and
uninfected cells were included as a control. The experiment was conducted in
triplicate (biological replicates), with a 3-way SILAC label swap. The full descrip-
tion of sample processing is continued in the Supplementary Methods file.
Data analysis, statistics, and reproducibility. Western blotting and immuno-
fluorescence images are representative of at least two independent biological
replicates. Random and sample barcodes in cRNA-seq and ribosome profiling data
were analyzed by trimming the sample and UMI barcodes and 3’ adapters from the
reads using our in-house computational genomics framework gedi (available at
https://github.com/erhard-lab/gedi). Barcodes introduced by the reverse tran-
scription primers included three random bases (UMI part 1) followed by four bases
of sample-specific barcode followed by two random bases (UMI part 2). Reads were
mapped using bowtie 1.0 against the human genome (hg19), the human tran-
scriptome (Ensembl 75) and HSV-1 (JN555585). The HSV-1 genome consists of
two components (L and S) that are both flanked by long repeats. To mitigate the
effect of multi-mapping reads, we masked the terminal repeats by NNN. The three
mappings were merged and only the alignments for a read with minimal number of
mismatches were retained. Reads were assigned to their specific samples based on
the sample barcode. Barcodes not matching any sample-specific sequence were
removed. PCR duplicates of reads mapped to the same genomic location were
identified by counting UMIs. If two observed UMI differed by only a single base,
one likely is due to a sequencing error. Thus, we discarded one of the two in such
cases. If the reads at this location mapped to k locations (i.e., multi-mapping reads
for k > 1), a fractional UMI count of 1/k was used (see Supplementary Table 1 for
read yields)11. Finally, all read mappings in the repeats were copied into the pre-
viously masked regions.
dRNA-seq, 4sU-seq, total RNA-seq and RNA-seq data of subcellular fractions
were processed similar to cRNA-seq and ribosome profiling data with the
exception of STAR (v.2.5.3a) being used to map the reads and PCR duplicates were
not collapsed as no random barcodes were used (see Supplementary Table 1 for
read yields).
All libraries were prepared with strand-sensitive protocols. Consequently, all
reads were mapped only to their respective strand. Further, reads were weighted by
the number of different locations they map to (i.e., if a read mapped to three
locations, its weight was 1/3).
Our dRNA-seq and cRNA-seq TiSS profiling data were analyzed with our TiSS
analysis pipeline iTiSS (integrative Transcriptional Start Site caller, see
Supplementary Methods), which identifies potential TiSS at single-nucleotide
resolution. Briefly, dRNA-seq and cRNA-seq data were searched for positions
showing strong accumulation of reads 5’ ends compared to their surroundings
using a sliding-window approach. Transcriptional activity was defined by having a
stronger transcriptional activity downstream of a potential TiSS than upstream
identified using Fisher’s exact test. Selective induction or repression (altered
expression kinetics) of the respective transcripts during the course of HSV-1
infection was defined by observing a significant change of transcriptional activity
surrounding a potential TiSS during the course of infection using a likelihood ratio
test based on the dirichlet distribution.
Each position in the viral genome could therefore score up to four points by
iTiSS. However, we extended the total number of criteria to 9 by including
additional evidence for the presence of a TiSS of other datasets or groups. The final
list of criteria are as follows (criteria i–iv are checked by iTiSS. For a more detailed
description see Supplementary Methods.):
(i) Significant accumulation of the 5′-end of reads in both replicates of the
dRNA-seq dataset at a single position of the HSV-1 genome.
(ii) Significant accumulation of the 5′-end of reads in both replicates of the
cRNA-seq dataset at a single position of the HSV-1 genome.
(iii) Stronger transcriptional activity downstream than upstream of the potential
TiSS in both cRNA-seq replicates.
(iv) Significant temporal changes in TiSS read levels during the course of
infection in both cRNA-seq replicates.
(v) A TiSS called in the MinION dataset with a maximum distance of 20 nt
downstream.
For this purpose, the transcripts provided in the Supplementary Table of
Depledge et al.14 were taken.
(vi)A TiSS called in the PacBio dataset in close proximity (±5 nt).
For this purpose, we manually corrected the GFF-file provided alongside the
GEO-submission for the PacBio data, which was inconsistent with the transcripts
reported in the paper.
(xii) Stronger transcriptional activity downstream than upstream of the
potential TiSS in both 4sU-seq replicates.
(viii) Significant temporal changes in TiSS read levels during the course of
infection in both 4sU-seq replicates.
(ix) The presence of an ORF at most 250 bp downstream, which was not yet
explained by another transcript.
Afterwards, potential TiSS within a ±5 bp window were combined into a
single TiSS. Consequently, a TiSS is defined by a single-nucleotide position
including a ±5 bp window. The fidelity of this definition can be appreciated by
the strong enrichment of the Inr motif even for the most weakly expressed viral
transcripts.
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The reported enrichment factors for dRNA-seq and cRNA-seq were calculated
based on predicted TiSS in human rather than HSV-1. This was done to prevent
undesired biases due to read-in caused by the extraordinary high number of
overlapping transcripts in HSV-1. The predicted TiSS were ordered based on the
number of reads starting at their respective positions. The median was then
calculated over the 50 strongest and 10 strongest expressed TiSS for cRNA-seq and
dRNA-seq, respectively.
Significance of the correlation between the presence of a TATA-box-like motif
and the transcription strength of TiSS was calculated using Fisher’s exact test. Here,
the TiSS were ordered by their numbers of reads starting and sorted into three
equally sized bins. For the bin containing the strongest TiSS as well as the bin
containing the weakest TiSS, the number of all nucleotides between position −30
and −25 relative to the TiSS were summed up. For the parameters of the Fisher’s
exact test, the following sums were used a= T+A(strongest bin), b=C+G
(strongest bin), c= T+A(weakest bin) and d= C+G(weakest bin).
We used our in-house tool PRICE5 version 1.0.1 to call ORFs separately for the
two replicates of ribosome profiling data but pooling all samples from each replicate.
RNA-seq data were mapped using STAR57 version 2.5.3a using a combined
reference index derived from Ensembl 90 and our final HSV-1 annotation.
We analyzed mass spectrometry data using MaxQuant58 version 1.6.5.0. Spectra
were matched against a combined database of proteins from Ensembl (version 75),
and all ORFs identified by ribosome profiling. We used carbamidomethylation as
fixed and acetylation (N-terminal) and oxidation at methionine as variable
modifications. Peptides were filtered for 1% FDR using the target-decoy approach
by MaxQuant.
The export indices of chromatin-associated RNA and cytoplasmic RNA were
derived by computing their fold changes between the wild-type and the null mutant
for ICP27 using the lfc R-package59. Data handling and visualization was done
using R including the ComplexHeatmap60, circlize61, ggseqlogo, ggplot2, reshape2,
plyr, scales, ggforce, ggrepel, and the gridExtra packages.
To reveal the potential function or functional motifs of predicted protein
sequences, we used sequence comparison, domain composition, structure
prediction and motif searches62–64. Sequence comparisons exploited Blast
searches iteratively65 and identified catalytic as well as regulatory domains
including predictions by the conserved domain database66. Predicted domain
composition was verified using domain databank tools SMART67 and Prodom68.
Motif searches exploited Prosite regular expressions and profiles and the
integrative protein signature database69. As independent tests for resulting
function assignments structure annotation for protein domains was done using
AnDOM software70 as well as homology predictions by SwissModel71. Gene
context methods were applied for unclear sequences related to non-viral
sequences (STRING database72). In addition, Clusters of Orthologous Groups
using the latest version (5.0) of the eggNOG tool with its 2502 virus strains
provided independent annotation input73.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All datasets generated and/or analyzed during the current study have been deposited in
the Gene Expression Omnibus (GEO) database with accession codes GSE128324
(Translation start site profiling, transcription start site profiling), GSE59717 (4sU-seq
and total RNA-seq), GSE60040 (ribosome profiling), and GSE128880 (cytoplasmic,
nucleoplasmic and chromatin-associated RNA). We only used the transcripts predicted
in the PacBio and MinION dataset, respectively. However, the raw data can be found at
the GEO database with accession code GSE97785 (PacBio)13, and from the European
Nucleotide Archive (ENA) with the study accession code PRJEB27861 (MinION)14. The
mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset identifiers PXD013010
and PXD013407. The revised annotation can be accessed at NCBI GenBank Third Party
Annotation database under the accession number BK012101. The source data underlying
Figs. 1, 2b–d,f, 3a, 4a–d, 5a–g, 6c, and Supplementary Fig. 5a–d are provided as a Source
Data file.
Code availability
Scripts used to create the Figures and Supplementary Data and Tables and analyze the
omics data are available at Zenodo74.
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